BioVie (BIVI) Earnings Analysis

BioVie (BIVI) next reports earnings on 2026-09-02, consensus EPS -0.52 USD. Last quarter (2026-05-11) it beat with EPS -0.7 USD vs -0.73 USD est (+4.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.91.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BIVI next report earnings?

Next earnings date2026-09-02
Consensus EPS estimate-0.52 USD
Revenue estimaten/a

BIVI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.7 USD-0.73 USD+4.1%Beat
2026-02-06-0.77 USD-0.81 USD+4.9%Beat
2025-11-10-0.98 USD-0.79 USD-24.1%Miss
2025-08-15-0.23617 USD-4.4 USD+94.6%Beat
2025-05-12-1.5 USD-3.2 USD+53.1%Beat
2024-09-30-66 USD-15 USD-340%Miss

Beat rate: 4/6 (67%) over reported quarters with consensus data.

BIVI valuation and analyst view

Trailing P/E-0.91
Trailing EPS-2.64007 USD
Price / book0.65
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (5 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is BioVie (BIVI)'s next earnings date?

BioVie is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.52 USD.

Did BIVI beat earnings last quarter?

In its 2026-05-11 report, BIVI posted EPS of -0.7 USD versus a -0.73 USD estimate — a beat of 4.1%.

What is BIVI's earnings track record?

Over the last 6 reported quarters with consensus data, BIVI beat estimates 4 times (67%).

What is BIVI's current P/E ratio and EPS?

BIVI trades at a trailing P/E of -0.91 on trailing EPS of -2.640068303984545 USD.

What do analysts rate BIVI?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell).